• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

522 Postmarket Surveillance Studies Database

  • Print
  • Share
  • E-mail
-
The FDA has the authority to require device manufacturers to perform postmarket surveillance under Section 522 of the Food, Drugs and Cosmetics (FD&C) Act, when questions are identified for devices that meet the statutory criteria. This database contains information about 522 Postmarket Surveillance Studies that have been required. This database allows you to search information about the postmarket surveillance requirements by manufacturer or device.

Learn more...

            
  To search for Manufacturer beginning with a specific letter, select that letter
 
 A 
 B 
 C 
 D 
 E 
 F 
 G 
 H 
 I 
 J 
 L 
 M 
 N 
 O 
 P 
 R 
 S 
 T 
 U 
 V 
 W 
 X 
 Z 
 
 
   

Human Factors Study


 
Suggest Enhancement / Report Issue | export reports to excelExport to Excel
General
Study Status Completed
522 Number / Requirement Number PS200002 / PSS001
Date Original Plan Accepted 06/23/2020
Date Current Plan Accepted 10/02/2020
Study Name Human Factors Study
Device Name Evis exera iii duodenovideoscope tjf-q190v
Root Document Number K193182 
General Study Protocol Parameters
Study Design Other Study Design
Data Source New Data Collection
Comparison Group No Control
Analysis Type Descriptive
Study Population
Detailed Study Protocol Parameters
Study Objectives The purpose of this HF validation test is to validate that the EVIS EXERA III DUODENOVIDEOSCOPE OLYMPUS TJF-Q190V's Reprocessing Manual (RM) is safe and effective for the intended users and uses, in the intended use environments. The HF validation test will also serve to identify any residual use errors that would or could result in serious harm, and to assess the effectiveness of risk management measures.

The HF validation test is designed to expose use errors (ie. mistakes) that could occur when the RM is placed into actual use. The HF validation test is also designed to collect participants' subjective feedback regarding their interactions with the RM.
Study Population The study population consists of Olympus TJF-Q190V model duodenoscopes.

In this simulation study, trained healthcare facility staff (including GI nurses and GI techs) will reprocess the scopes in accordance with the manufacturer’s duodenoscope reprocessing manual.
Sample Size At least 5 participants representative of GI/Endoscopy Nurses and at least 5 participants representative of GI/Endoscopy Technicians will be tested (total of 10 test participants, at minimum).
Key Study Endpoints This is a simulation human factors study that does not have the traditional safety assessments. The objective of this study is to show that individuals experienced in pre-cleaning and reprocessing of duodenoscopes can successfully read, understand and perform specific tasks as described in the RM. A detailed assessment of the results on user performance data, subjective data, and knowledge data will be performed and, if necessary, mitigations will be employed in situations where failures to successfully follow instructions, as written in the RMs, have been identified.
Interim or Final Data Summary
Final Effectiveness Findings Olympus’ supplemental human factors study was conducted with five (5) GI nurses and five (5) GI techs and evaluated user understanding of and adherence to the current reprocessing materials for TJF-Q190V duodenoscopes in the following core reprocessing areas: precleaning, manual cleaning, manual high[1]level disinfection, rinsing, and storage and disposal. GI nurses had successful performance on the sixteen (16) precleaning critical tasks, obtaining 100% success. GI techs are responsible for accessory inspection, leak testing, manual cleaning, manual high-level disinfection, and presoaking. The combined reprocessing performance success for the GI techs was 96%. For accessory inspections, 30 out of 35 tasks were successfully performed (86%). Similarly, success rates for other critical tasks were high: leak testing (93%); manual cleaning (98%); manual high-level disinfection (94%); and presoaking (99%). Finally, participants demonstrated high understanding of critical information in the IFU and user manuals, with knowledge task success rates of 100% for GI nurses and 98% for GI techs. These results, when taken together with the HF testing that was previously conducted for TJF-Q190V reprocessing instructions in the 510(k) submission, demonstrate that the current reprocessing user materials for TJF-Q190V duodenoscopes are sufficient to achieve a high user success rate for user performance and knowledge of reprocessing tasks.


Human Factors Study Reporting Schedule

Reporting Schedule
Report
Date Due
FDA Receipt
Date
Applicant's Reporting Status
3 month report 09/21/2020 09/22/2020 On Time
final report 04/17/2022 01/04/2021 On Time


Contact Us


Mandated Studies Program
Food and Drug Administration
10903 New Hampshire Ave.
Silver Spring, MD 20993-0002
Email: MandatedStudiesPrograms@fda.hhs.gov

Additional Resources


-
-